# Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease

> **NCT06568029** · — · COMPLETED · sponsor: **Karolinska Institutet** · enrollment: 77651 (actual)

## Conditions studied

- Rheumatoid Arthritis
- Polyarthritis
- Psoriatic Arthritis
- Ankylosing Spondylitis
- Rheumatic Diseases

## Interventions

- **OTHER:** Questionnaire

## Key facts

- **NCT ID:** NCT06568029
- **Lead sponsor:** Karolinska Institutet
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-08-16
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 77651 (ACTUAL)
- **Last updated:** 2025-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568029

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568029, "Construct Validity and Responsiveness of EQ-5D-3L in Patients With Rheumatic Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06568029. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*